166 related articles for article (PubMed ID: 32370640)
1. Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data.
Chen WC; Wang C; Li H; Lu N; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2020 May; 30(3):508-520. PubMed ID: 32370640
[TBL] [Abstract][Full Text] [Related]
2. Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies.
Wang C; Lu N; Chen WC; Li H; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2020 May; 30(3):495-507. PubMed ID: 31707908
[TBL] [Abstract][Full Text] [Related]
3. Propensity score-incorporated adaptive design approaches when incorporating real-world data.
Lu N; Chen WC; Li H; Song C; Tiwari R; Wang C; Xu Y; Yue LQ
Pharm Stat; 2024; 23(2):204-218. PubMed ID: 38014753
[TBL] [Abstract][Full Text] [Related]
4. Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies.
Wang C; Li H; Chen WC; Lu N; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2019; 29(5):731-748. PubMed ID: 31530111
[TBL] [Abstract][Full Text] [Related]
5. Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources.
Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 Jan; 32(1):158-169. PubMed ID: 34756158
[TBL] [Abstract][Full Text] [Related]
6. Leverage multiple real-world data sources in single-arm medical device clinical studies.
Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 Jan; 32(1):107-123. PubMed ID: 33844621
[TBL] [Abstract][Full Text] [Related]
7. Replication of Oncology Randomized Trial Results using Swedish Registry Real World-Data: A Feasibility Study.
Jemielita T; Widman L; Fox C; Salomonsson S; Liaw KL; Pettersson A
Clin Pharmacol Ther; 2021 Dec; 110(6):1613-1621. PubMed ID: 34549809
[TBL] [Abstract][Full Text] [Related]
8. Propensity score-integrated approach to survival analysis: leveraging external evidence in single-arm studies.
Chen WC; Lu N; Wang C; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 May; 32(3):400-413. PubMed ID: 35675348
[TBL] [Abstract][Full Text] [Related]
9. Bayesian Divide-and-Conquer Propensity Score Based Approaches for Leveraging Real World Data in Single Arm Clinical Trials.
Baron E; Zhu J; Tang RS; Chen MH
J Biopharm Stat; 2022 Jan; 32(1):75-89. PubMed ID: 35094643
[TBL] [Abstract][Full Text] [Related]
10. Emulating Randomized Controlled Trials with Hybrid Control Arms in Oncology: A Case Study.
Sengupta S; Ntambwe I; Tan K; Liang Q; Paulucci D; Castellanos E; Fiore J; Lane S; Micsinai Balan M; Viraswami-Apanna K; Sethuraman V; Samant M; Tiwari R
Clin Pharmacol Ther; 2023 Apr; 113(4):867-877. PubMed ID: 36606735
[TBL] [Abstract][Full Text] [Related]
11. Utilization of anonymization techniques to create an external control arm for clinical trial data.
Mehtälä J; Ali M; Miettinen T; Partanen L; Laapas K; Niemelä PT; Khorlo I; Ström S; Kurki S; Vapalahti J; Abdelgawwad K; Leinonen JV
BMC Med Res Methodol; 2023 Nov; 23(1):258. PubMed ID: 37925415
[TBL] [Abstract][Full Text] [Related]
12. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
Liu M; Bunn V; Hupf B; Lin J; Lin J
Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
[TBL] [Abstract][Full Text] [Related]
13. A Bayesian nonparametric causal inference model for synthesizing randomized clinical trial and real-world evidence.
Wang C; Rosner GL
Stat Med; 2019 Jun; 38(14):2573-2588. PubMed ID: 30883861
[TBL] [Abstract][Full Text] [Related]
14. Practical considerations of utilizing propensity score methods in clinical development using real-world and historical data.
Li Q; Lin J; Chi A; Davies S
Contemp Clin Trials; 2020 Oct; 97():106123. PubMed ID: 32853779
[TBL] [Abstract][Full Text] [Related]
15. Trial designs using real-world data: The changing landscape of the regulatory approval process.
Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
[TBL] [Abstract][Full Text] [Related]
16. Confounding adjustment in the analysis of augmented randomized controlled trial with hybrid control arm.
Li L; Jemielita T
Stat Med; 2023 Jul; 42(16):2855-2872. PubMed ID: 37186394
[TBL] [Abstract][Full Text] [Related]
17. Matching design for augmenting the control arm of a randomized controlled trial using real-world data.
Liu Y; Lu B; Foster R; Zhang Y; Zhong ZJ; Chen MH; Sun P
J Biopharm Stat; 2022 Jan; 32(1):124-140. PubMed ID: 35098880
[TBL] [Abstract][Full Text] [Related]
18. Beyond Randomized Clinical Trials: Use of External Controls.
Schmidli H; Häring DA; Thomas M; Cassidy A; Weber S; Bretz F
Clin Pharmacol Ther; 2020 Apr; 107(4):806-816. PubMed ID: 31725899
[TBL] [Abstract][Full Text] [Related]
19. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
Wang X; Suttner L; Jemielita T; Li X
J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
